UNSPSC 51286801: Chlorquinaldol

This classification denotes a topical anti-infective agent with the molecular formula C10H7Cl2NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D6VHC87LLS, chemically known as 5,7-dichloro-8-quinaldinol but more generally known as chlorquinaldol, which bears US NIH Compound Identifier 6301. European Medicines Agency schedules Chlorquinaldol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06211MIG. The term CHLORQUINALDOL is an International Non-Proprietary Name.

The World Health Organization schedules chlorquinaldol in its Anatomical Therapeutic Chemical (ATC) Classification. CHLORQUINALDOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC1=NC2=C(C=C1)C(=CC(=C2O)CL)CL.

UNSPSC 51286801 Chlorquinaldol is a Commodity code that appears in state and local procurement activity with limited recent visibility — the opportunities on record show no open solicitations currently seeking chlorquinaldol itself. The two most recent tagged opportunities reflect pharmaceutical supply chain work across different product lines: an Illinois Department of Public Health piggyback contract award (completed August 2026) for antibiotic tablets through MMCAP Infuse, and a Seminole County, Florida IFB for naloxone and drug deactivation systems. State and local health agencies and counties use UNSPSC codes in this family to classify pharmaceutical procurement, including both scheduled and emergency medical countermeasures, though tagging precision varies by jurisdiction and procurement vehicle.

Geographic activity in recent months centers on Florida and Illinois, with Seminole County and the Illinois Department of Public Health appearing as recent buyers in the pharmaceutical space. The Illinois award — a $2,999,999.11 contract with Chartwell Rx LLC covering doxycycline hyclate and ciprofloxacin under a 12-month term plus renewal options — illustrates the scale of state health department pharmaceutical procurement through cooperative purchasing vehicles. Seminole County's July 2026 IFB sought 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to the county community health building, reflecting municipal and county-level demand for opioid-reversal and harm-reduction supplies. No active open solicitations for chlorquinaldol specifically appear in current state and local notice streams; procurement under this code may occur through existing vendor agreements, cooperative purchasing contracts, or standing orders rather than through competitive RFP or IFB cycles.